Chip startup d-Matrix Inc. today disclosed that it has raised $275 million in funding to support its commercialization ...
BOSTON — As the use of biologic drugs becomes more widespread, optometrists need to be aware of the downstream impacts they could have on patients’ ocular health, according to speakers here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback